Back to Top Skip to main content Skip to sub-navigation

DoD Establishes Collaborative Virus Genetic Sequencing Capability for COVID-19

Image of two scientists in masks looking at a computer monitor Research associate Lindsay Glang and senior bioinformatics analyst Gregory Rice sequencing SARS-CoV-2 genomes on Oxford Nanopore MinION platform at NMRC BDRD. (Photo Courtesy of Naval Medical Research Center, Genomics & Bioinformatics Department.)

Recommended Content:

Armed Forces Health Surveillance Division | Coronavirus | Global Emerging Infections Surveillance

As the pandemic continues to unfold, genetic sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19), has played a critical role in the public health response, including in the design of diagnostics and vaccines. Within the Department of Defense, SARS-CoV-2 genetic sequence data plays a vital role in force health protection efforts.

To jumpstart the DoD’s SARS-CoV-2 sequencing efforts, Armed Forces Health Surveillance Branch’s Global Emerging Infections Surveillance (GEIS) section used its existing partnerships with Army, Navy, and Air Force public health and medical research laboratories. This connection helped to establish a collaborative approach to the sequencing capabilities. Sequence data from this collaboration will provide critical information about transmission patterns, track diagnostic effectiveness, and guide the development and evaluation of medical countermeasures for the 1.4 million active duty and 331,000 reserve personnel.

“GEIS-funded surveillance provides near-real time understanding of how the SARS-CoV-2 virus is evolving. This information is critical for the development of a vaccine and treatment,” stated Navy Capt. Guillermo Pimentel, GEIS chief. “Previous investments by GEIS in this technology have given our partners the capability to respond and sequence SARS-CoV-2 genomes isolated from DoD Service members around the world.”

In 2017, GEIS established a Next Generation Sequencing and Bioinformatics Consortium to work with GEIS partner DoD laboratories to coordinate and improve pathogen sequencing and analysis efforts around the world. Consortium partners can rapidly detect and characterize known, emerging, and novel infectious disease agents using data from pathogen sequencing. This helps to inform force health protection decision making. The core Consortium partners include: the Naval Medical Research Center (NMRC), U.S. Army Medical Research Institute of Infectious Diseases, Walter Reed Army Institute of Research, U.S. Air Force School of Aerospace Medicine, and the Naval Health Research Center.

“We have used virus sequence data in numerous studies to track virus transmission [such as dengue and influenza],” said Irina Maljkovic Berry, chief of Viral Genetics and Emerging Diseases for the WRAIR Viral Diseases Branch in Silver Spring, Maryland. “We estimate outbreak origins to detect and track vaccine escape and other important mutations throughout the world to aid in vaccine design.”

Consortium partners played a key role in analyzing previous viral outbreaks, such as Ebola in West Africa and Zika in South America, and in seasonal influenza vaccine selection. "Each year we generate thousands of influenza genomes that we use to determine how influenza is evolving or evading our vaccines which directly impact our forces," said Clarise Starr, deputy chief of Pathogen Detection and Therapeutics Portfolio Applied Technology and Genomics Division, U.S. Air Force School of Aerospace Medicine. "These efforts will be the same essential practices that we'll need to deploy in response to SARS-CoV-2."

This open partnership and investment proved extremely helpful in response to the COVID-19 pandemic. DoD laboratories quickly established the ability to isolate the virus, share samples, and compare laboratory methods to improve their sequencing capabilities. “We have been evaluating a few different laboratory sequencing protocols to determine which one works best for samples with certain attributes, in order help increase the efficiency of SARS-CoV-2 sequencing from swabs,” according to Kimberly Bishop-Lilly, head of Genomics & Bioinformatics Department at NMRC in Fort Detrick, Maryland.

The sequence data that's being collected is a valuable source of information to better understand virus transmission patterns among DoD personnel, particularly when combined with other clinical and epidemiological data. These data are also compared to global virus sequence data.

“The goal is to have data and information that could help answer how local outbreaks may have started, how SARS-CoV-2 may have spread in a community or geographic area, and how we can better contain spread or improve interventions,” said Lindsay Morton, GEIS’s senior molecular epidemiologist. Thus far, SARS-CoV-2 sequence data has been gathered from infected personnel at more than 25 locations across the globe.

Additionally, GEIS partners are leveraging this technology to improve understanding of global circulation of SARS-CoV-2 through surveillance programs at DoD overseas labs, such as in Thailand, Peru, Kenya, and Cambodia.

“The OCONUS (Outside Continental United States) labs are starting to stand up SARS-CoV-2 sequencing capabilities and the core labs of the Consortium are providing them reach-back support for sequencing protocols and for bioinformatics analyses,” said Bishop-Lilly. “Consensus viral genomes are being produced at some of the OCONUS labs and we are comparing to viral genomes obtained from samples in other regions such as the U.S., to identify what lineage is predominant in a given geographic region and what key genetic variations may be predominant in a certain area.”

These data will provide a better understanding of transmission in these locations and result in a better understanding of risk to U.S. forces deployed around the world as the COVID-19 pandemic continues. GEIS leaders hope that increased collaboration across the agencies will propel the research and production of an effective vaccine.

“The key to fully utilizing SARS-CoV-2 sequence data is collaboration,” said Morton, “Consortium partners are ready and willing to engage with organizations involved with clinical studies and outbreak investigations across the DoD to better guide the Department’s response to COVID-19 and reduce the impact to readiness and operations around the world.”

You also may be interested in...

VAX Fact Current Infection

Infographic
4/19/2021
VAX Facts: Can I get a COVID-19 vaccine if I currently have a positive COVID-19 infection: No. People with a COVID-19 positive test result or illness symptoms should wait to be vaccinated until they recover and meet the criteria for discontinuing isolation.  This also applies if you get COVID-19 between a first and second vaccine dose.

An infographic answering the question of whether to get the COVID-19 vaccine if you currently have a positive COVID-19 infection.

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Affect Fertility

Infographic
4/19/2021
VAX Fact: Does a COVID-19 vaccine affect my fertility? There is currently no evidence of fertility impacts due to COVID-19 vaccines.  If you are trying to conceive or want to get pregnant in the future, you may choose to receive a COVID-19 vaccine when one is available.

An infographic answering the question of whether the COVID-19 vaccine affects a person's fertility.

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Appenzeller emphasizes: Get COVID-19 vaccine, no matter where

Article
4/16/2021
Military personnel explaining forensic equipment

The DHA’s Combat Support assistant director had some direct and encouraging words about the military’s COVID-19 vaccine rollout to date.

Recommended Content:

COVID-19 Vaccine Toolkit | MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Toolkit

Tele-critical care will play increased COVID-19 response role in 2021

Article
4/15/2021
Infographic that says "202 tele-critical care successes will help 2021 COVID19 response"

Virtual health and particularly tele-critical care for critically ill patients assumed frontline roles in sustaining care while keeping beneficiaries and health care teams safe.

Recommended Content:

Coronavirus | Health Innovation Month

Join Us!! Third COVID-19 Townhall Update with Major General George Appenzeller!

Article
4/13/2021
MHS and Military OneSource COVID-19 Townhall, with Major General (Dr.) George N. Appenzeller.  Wednesday, 14 April, 1 PM ET

Join us for the MHS' Third COVID-19 Townhall with Major General George Appenzeller

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | MHS and Military OneSource To Your Health

DOD surpasses 2 million COVID-19 vaccines worldwide

Article
4/9/2021
Military health personnel wearing a face mask and a face shield giving the COVID-19 vaccine

The DOD hit the 2 million mark for vaccinations worldwide just a month after the 1 million milestone.

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Public health remains an integral part in the fight against COVID

Article
4/9/2021
Infographic featuring health personnel wearing face shields and mask with "National Public Health Week" across the top of the picture

The pandemic has highlighted a need to provide more advanced training on infection prevention and control.

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Sexual Assault Awareness & Prevention Toolkit | Public Health | Coronavirus | COVID-19 Vaccine Toolkit

Children’s well-being contributes immeasurably to force readiness

Article
4/6/2021
Military personnel wearing face mask in the back of a truck

The Defense Health Agency joins in celebrating military children during Month of the Military Child, observed in April, and always.

Recommended Content:

MHS Toolkits and Branding Guidance | Children's Health | Coronavirus | Month of the Military Child Toolkit | $name

Telemedicine advances put to the test during pandemic

Article
4/1/2021
Uniformed service member stands behind wall of computer screens

COVID-19 has led to the need for physical distancing and has overwhelmed the capacities of health systems, compelling many to adopt telehealth solutions.

Recommended Content:

Technology | Research and Innovation | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Toolkit | Health Innovation Month

Lovell FHCC staff steps up to create formidable COVID-19 team

Article
3/30/2021
Military health personnel preparing to administer the COVID-19 vaccine

The COVID-19 vaccination effort at the Capt. James A. Lovell Federal Health Care Center in North Chicago, Illinois, has brought out the best in staff.

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

DOD healthcare leaders give COVID-19 update, praise DHA personnel

Article
3/30/2021
Picture of Director Army Lt. Gen. (Dr. Ronald Place providing a COVID-19 update at  the Pentagon

Dr. Terry Adirim and Army Lt. Gen. (Dr.) Ronald Place provide update on COVID-19 vaccination progress and offer thanks to MHS workers for their contributions.

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Dover Air Force Base features ‘Park ‘N Pickup’ pharmacy

Article
3/26/2021
Picture of prescription sitting on a counter

Due to the increased need for patient safety, the 436th Medical Group pharmacy at Dover Air Force Base has implemented a Park ‘N Pickup process.

Recommended Content:

MHS Toolkits and Branding Guidance | Coronavirus | Patient Safety

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA Form 207: COVID-19 Vaccine Screening and Immunization Document, v16

Form/Template
3/25/2021

The purpose of this form is to determine if the COVID-19 vaccine can be administered to the patient. (v16, October 2021)

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | COVID-19 Information for Military Treatment Facility Directors
<< < ... 6 7 8 9 10  ... > >> 
Showing results 106 - 120 Page 8 of 47

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.